You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Selective improvement by rifaximin of changes in the immunophenotype in patients who improve minimal hepatic encephalopathy
|
---|---|
Published in |
Journal of Translational Medicine, August 2019
|
DOI | 10.1186/s12967-019-2046-5 |
Pubmed ID | |
Authors |
Alba Mangas-Losada, Raquel García-García, Paola Leone, María Pilar Ballester, Andrea Cabrera-Pastor, Amparo Urios, Juan-José Gallego, Juan-José Martínez-Pretel, Carla Giménez-Garzó, Fernando Revert, Desamparados Escudero-García, Joan Tosca, María Pilar Ríos, Cristina Montón, Lucia Durbán, Luis Aparicio, Carmina Montoliu, Vicente Felipo |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 2 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 1 | 50% |
Members of the public | 1 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 25 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 7 | 28% |
Other | 3 | 12% |
Librarian | 2 | 8% |
Lecturer | 1 | 4% |
Student > Ph. D. Student | 1 | 4% |
Other | 3 | 12% |
Unknown | 8 | 32% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 6 | 24% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 12% |
Arts and Humanities | 1 | 4% |
Biochemistry, Genetics and Molecular Biology | 1 | 4% |
Neuroscience | 1 | 4% |
Other | 0 | 0% |
Unknown | 13 | 52% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 June 2023.
All research outputs
#15,099,350
of 23,978,545 outputs
Outputs from Journal of Translational Medicine
#1,931
of 4,252 outputs
Outputs of similar age
#190,928
of 343,476 outputs
Outputs of similar age from Journal of Translational Medicine
#38
of 71 outputs
Altmetric has tracked 23,978,545 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,252 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.9. This one has gotten more attention than average, scoring higher than 50% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 343,476 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 71 others from the same source and published within six weeks on either side of this one. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.